THE INSTITUTE OF HUMAN VIROLOGY NIGERIA (IHVN)

The Institute of Human Virology Nigeria (IHVN) was established in 2004 as an affiliate of the Institute of Human Virology, University of Maryland School of Medicine, Baltimore, USA. In furtherance of its  sustainability goals, the University of Maryland, Baltimore facilitated the re-incorporation of IHVN in March 2004 as an indigenous, non-governmental organization in Nigeria. The vision of IHVN is to be a leader in providing quality health Services, capacity building and research in Africa.


IHVN conducts biomedical research with a thematic focus on HIV/AIDS, COVID-19, malaria, and tuberculosis. The research activities of the institute also extend to implementation science, with the purpose of guiding informed policy and evidence-based practice. Prof. Alash’le Abimiku leads the International Research Center of Excellence (IRCE), which plays a central role in spearheading  all the institutes research activities.


The Institute’s key technical and funding partners include the Centers for Disease Control and Prevention (CDC) and the Global Fund to Fight AIDS, Tuberculosis and Malaria. IHVN is one of the two institutions leading the INFORM Africa research hub.

Follow the link below to learn more about IHVN!

THE CENTRE FOR THE AIDS PROGRAMME OF RESEARCH IN SOUTH AFRICA (CAPRISA)

CAPRISA was formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Research and Policy; and is the South African Department of Science and Innovation and the National Research Foundation‘s designated Centre of Excellence in HIV Prevention. 

 

 

CAPRISA undertakes high-impact globally relevant and locally responsive research on HIV, TB and SARS-CoV-2 epidemiology, pathogenesis, prevention and treatment. To achieve this goal, CAPRISA conducts research mainly in four scientific programmes: 1) HIV and SARS-CoV-2 pathogenesis and vaccines, 2) HIV and TB treatment, 3) HIV epidemiology and prevention and 4) Pandemic preparedness and epidemic intelligence. 

 

Research activities at CAPRISA are supported by eight support cores including, administration, statistics, data management, laboratory, community, pharmacy, bioethics, and information systems.The fiduciary and policy oversight of CAPRISA is governed by the Board of Control with senior industry officials. The CAPRISA Scientific Advisory Board is chaired by Nobel Laureate, Professor Françoise Barré-Sinoussi, Emeritus Professor at the Institut Pasteur in Paris. CAPRISA is one of the two institutions leading the INFORM Africa research hub. 

 

 Follow the link below to learn more about CAPRISA!